Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros

Revista
Tipo del documento
Intervalo de año
1.
Int J Environ Res Public Health ; 20(3)2023 01 29.
Artículo en Inglés | MEDLINE | ID: covidwho-2247813

RESUMEN

Public heath emergencies such as the outbreak of novel infectious diseases represent a major challenge for drug regulatory bodies, practitioners, and scientific communities. In such critical situations drug regulators and public health practitioners base their decisions on evidence generated and synthesised by scientists. The urgency and novelty of the situation create high levels of uncertainty concerning the safety and effectiveness of drugs. One key tool to mitigate such emergencies is pandemic preparedness. There seems to be, however, a lack of scholarly work on methodology for assessments of new or existing drugs during a pandemic. Issues related to risk attitudes, evidence production and evidence synthesis for drug approval require closer attention. This manuscript, therefore, engages in a conceptual analysis of relevant issues of drug assessment during a pandemic. To this end, we rely in our analysis on recent discussions in the philosophy of science and the philosophy of medicine. Important unanswered foundational questions are identified and possible ways to answer them are considered. Similar problems often have similar solutions, hence studying similar situations can provide important clues. We consider drug assessments of orphan drugs and drug assessments during endemics as similar to drug assessment during a pandemic. Furthermore, other scientific fields which cannot carry out controlled experiments may guide the methodology to draw defeasible causal inferences from imperfect data. Future contributions on methodologies for addressing the issues raised here will indeed have great potential to improve pandemic preparedness.


Asunto(s)
Urgencias Médicas , Pandemias , Humanos , Pandemias/prevención & control , Aprobación de Drogas , Salud Pública , Brotes de Enfermedades
2.
Sci ; 5(1):7.0, 2023.
Artículo en Inglés | MDPI | ID: covidwho-2226995

RESUMEN

During the global Corona pandemic, the validity of science has been challenged by sections of the public, often for political gains [...]

3.
Sci ; 4(1):10, 2022.
Artículo en Inglés | MDPI | ID: covidwho-1732180

RESUMEN

Sci (ISSN 2413-4155) is an international, open-access journal that covers most fields of scientific research. It has set out to challenge the conventional single- and double-blind peer review processes by adopting a post-publication public peer review (P4R) model. The model faced some difficulties with indexing and archiving services, prolongated the peer review process and its transparency received some opposition. It was therefore necessary to revisit the P4R model and modify it, resulting in the hybrid model (P4R hybrid) which is implemented in Sci today. Sci remains open to the whole scientific community as an inclusive and multidisciplinary scientific journal. In this context, we present you with six valuable contributions to the first Special Issue of Feature Papers Editors Collection 2020. The topics of the contributions address relevant and compelling issues ranging from data protection, material science, COVID-19 to the environment and climate change.

4.
Int J Environ Res Public Health ; 18(24)2021 12 07.
Artículo en Inglés | MEDLINE | ID: covidwho-1555017

RESUMEN

The COVID-19 pandemic has affected populations globally, including Ghana. Knowledge of the COVID-19 disease, and the application of preventive public health interventions are pivotal to its control. Besides a lockdown, measures taken against the spread of the virus include the wearing of face masks, social distancing, regular hand washing with soap and, more recently, vaccination against the virus. In order to establish a possible link between the knowledge of the disease and compliance with preventive measures, including vaccination, a cross-sectional study employing an interview-structured questionnaire was conducted in six regions of Ghana (n = 1560). An adequate level of knowledge of COVID-19 (69.9%) was reported. The linear multiple regression analysis further explicated the differences in the knowledge of COVID-19 among the respondents by their knowledge of cholera and influenza (adjusted R-Square = 0.643). Despite this profound knowledge of the illness, two thirds of the respondents were unwilling to follow basic preventive measures and only 35.3% were willing to be vaccinated. Amazingly, neither knowledge of COVID-19 nor the socio-demographic characteristics had any meaningful influence on the practice of preventive measures. Personal attitude leading to efficient public compliance with preventive measures, therefore, is a critical issue demanding special attention and effective interventions by the government and locals with authority to curb the spread of the pandemic which surpasses the traditional channels of public health communication. This includes a roll-out of persuasion, possibly including public figures and influencers, and in any case, a balanced and open discussion addressing the acceptance of the COVID-19 vaccine in order to avoid new variants and comparable problems currently facing many countries of Western Europe. Indeed, a profound hesitancy against vaccination may turn African countries such as Ghana for many years into hotspots of new viral variants.


Asunto(s)
COVID-19 , Pandemias , Vacunas contra la COVID-19 , Control de Enfermedades Transmisibles , Estudios Transversales , Ghana/epidemiología , Conocimientos, Actitudes y Práctica en Salud , Humanos , SARS-CoV-2 , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA